Global Pharmacovigilance Market Forecast Report to 2026 – Rise in Pharmacovigilance Applications in Spontaneous Reporting and Electronic Health Record (EHR) Mining – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Pharmacovigilance Market Research Report by Type (Contract Outsourcing and In-house), Clinical Trial, Method, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2026 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.

The Global Pharmacovigilance Market size was estimated at USD 5,844.39 million in 2020, USD 6,669.16 million in 2021, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 14.79% to reach USD 13,376.20 million by 2026.

Market Segmentation & Coverage:

This research report categorizes the Pharmacovigilance to forecast the revenues and analyze the trends in each of the following sub-markets:

• Based on Type, the market was studied across Contract Outsourcing and In-house.
• Based on Clinical Trial, the market was studied across Phase I, Phase II, Phase III, Phase IV, and Pre-clinical.
• Based on Method, the market was studied across Cohort Event Monitoring, EHR Mining, Intensified ADR Reporting, Spontaneous Reporting, and Targeted Spontaneous Reporting.
• Based on End User, the market was studied across Academic & Research Institutes, Government Agencies, Health Insurance Companies, Hospitals & Care Providers, and Pharma & Biotech Companies.
• Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa.

Market Dynamics

• Drivers
  • Increase in the Prevalence of Chronic Diseases
  • Rise in Pharmacovigilance Applications in Spontaneous Reporting and Electronic Health Record (EHR) Mining
  • Rise in Demand for Outsourcing Services by Players
  • Rising Incidence of ADR and Drug Toxicity
• Restraints
  • High-cost Technology for Small and Mid-sized Players
• Opportunities
  • Emergence of COVID-19 have Opened New Opportunities
  • Rising Investment in Research and Development (R&D) by Healthcare Companies
• Challenges
  • Lack of Skilled Labor

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

The report provides insights on the following:

• Market Penetration: Provides comprehensive information on the market offered by the key players
• Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
• Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
• Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
• Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

Companies Mentioned

• Accenture, PLC
• Bristol Myers Squibb
• C.H. Boehringer Sohn AG & Ko. KG
• Capgemini SE
• ClinChoice Inc.
• F. Hoffmann-La Roche AG
• GlaxoSmithKline PLC
• HCL Technologies Limited
• ICON PLC
• Infosys Limited
• International Business Machines Corporation
• IQVIA
• ITclinical
• Laboratory Corporation
• Linical Co
• Novartis International
• Oracle Corporation
• Parexel
• Pfizer Inc.
• Quanticate International
• Sanofi S.A.
• Take Solutions Ltd.
• Tata Consultancy Services
• Wipro

For more information about this report visit https://www.researchandmarkets.com/r/xg62et

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900